Management of shvitra or vitiligo with the help of panchakarma

Clinico Comparative Study of Vamana Virechana In The Management Of Shvitra WSR To Vitiligo

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/09/005004

Enrollment

100

Registered

2014-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients having sign symptoms of vitiligo(shvitra)

Interventions

Intervention1: Group A: Vamana Karma followed by Apamargkshar Lepa and Darvigomootra Ghanavati 6gm/day in form of 500mg tablet in three divided dose for 2months Control Intervention1: group a: vamana

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sign and symptoms of shvitra(Vitiligo) Patients between age group of 15 years to 50 years will be selected. Patients having chronicity less than 10 yrs

Exclusion criteria

Exclusion criteria: Patients complicated with any Cardiovascular diseases, Renal diseases, Hepatic Disease, Carcinoma, Major illness ike IDDM, NIDDM, Patches due to burning, Chemical explosion, any other serious systematic illness or any other disease effecting multiple body systems and pregnant women etc. Patients contraindicated for Vamana Virechana Karma as per classics.

Design outcomes

Secondary

Measure	Time frame
maintenance of repigmentation, stabilization of vitiligo and side-effects,quality of lifeTimepoint: 2 months	—

Primary

Measure	Time frame
repigmentation change in vasi scoreTimepoint: 2 months	—

Countries

India

Contacts

Public ContactHemang U Raghavani

IPGT RA

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026